Inventor
Garrick Packard
Inventor
San Diego, CA, US
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium14%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry3%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
10,683,298Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors202010,577,378EIF4A-inhibiting compounds and methods related thereto202010,167,290Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors20199,957,277eIF4A-inhibiting compounds and methods related thereto20189,771,371'Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors'20179,193,692'Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors'20159,079,900'Methods of synthesis and purification of heteroaryl compounds'20158,907,087'Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors'20148,569,494'Methods of synthesis and purification of heteroaryl compounds'20138,507,492'Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway'20138,492,381'Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway'20138,372,976'Methods of treatment comprising the administration of heteroaryl compounds'20138,299,056'Aminotriazolopyridines, compositions thereof, and methods of treatment therewith'20128,110,578'Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway'20127,981,893'Heteroaryl compounds, compositions thereof, and methods of treatment therewith'20116,831,175'Kinase inhibitors'2004Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2004–2020Based in San Diego, CA, US· patent location history
2011–2020Patents assigned to SIGNAL PHARM LLC (13)· patent assignee history
2012–2013Patents assigned to ELSNER JAN (5)· patent assignee history
2012–2013Patents assigned to PACKARD GARRICK (5)· patent assignee history
2012–2013Patents assigned to PAPA PATRICK (5)· patent assignee history
2012–2013Patents assigned to PERRIN-NINKOVIC SOPHIE (5)· patent assignee history
2014–2015Based in Minneapolis, MN, US· patent location history
2017–2020Based in Humbird, WI, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SIGNAL PHARM LLC | 13 | 2011–2020 |
| ELSNER JAN | 5 | 2012–2013 |
| PACKARD GARRICKself | 5 | 2012–2013 |
| PAPA PATRICK | 5 | 2012–2013 |
| PERRIN-NINKOVIC SOPHIE | 5 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 10 | 2004–2020 |
| Humbird, WI, US | 3 | 2017–2020 |
| Minneapolis, Minnesota, US | 3 | 2014–2015 |